Skip to content
Clinical Trials – home

LAUROMACROGOL 400: A Comprehensive Guide for Patients

3 / 3
trials open to patients / all trials
5+
Countries

In short

Lauromacrogol 400, also known as polidocanol, is a medication being studied in various clinical trials for its potential in treating vascular and gastrointestinal conditions. These trials aim to evaluate its effectiveness and safety in addressing issues such as venous insufficiency, hemorrhoids, and gastric varices. The studies explore different formulations and applications of Lauromacrogol 400, comparing it to other treatments and assessing its impact on patient outcomes.

What is Lauromacrogol 400?

Lauromacrogol 400, also known as polidocanol, is a medical compound used in various treatments, primarily for vascular conditions. It belongs to a class of drugs called sclerosing agents, which means it can cause controlled damage to blood vessels, leading to their closure. This property makes it useful in treating conditions where problematic blood vessels need to be eliminated.

Medical Uses of Lauromacrogol 400

Lauromacrogol 400 is used to treat several medical conditions, including:

  • Venous insufficiency: A condition where veins have trouble sending blood from the legs back to the heart
  • Hemorrhoids: Swollen veins in the lower rectum and anus
  • Gastric varices: Enlarged veins in the stomach, often due to liver disease

Treatment of Venous Insufficiency

For venous insufficiency, Lauromacrogol 400 is used in a procedure called sclerotherapy. In this treatment, the drug is injected into problematic veins, causing them to close and eventually be reabsorbed by the body. This helps improve blood flow and reduce symptoms like leg pain and swelling.

Research is ongoing to determine the most effective concentration of Lauromacrogol 400 for treating venous insufficiency. One study is comparing 3% versus 1% concentrations to evaluate their efficacy and tolerance.

Treatment of Hemorrhoids

Lauromacrogol 400 is also used to treat internal hemorrhoids. In this application, it's used in a procedure called endoscopic foam sclerotherapy. The drug is turned into a foam and injected into the hemorrhoids using a special instrument (endoscope) that allows the doctor to see inside the rectum.

This treatment aims to reduce bleeding, itching, and the size of the hemorrhoids. Researchers are studying whether the foam version of Lauromacrogol 400 is more effective than the liquid version for treating hemorrhoids.

Treatment of Gastric Varices

Gastric varices are enlarged veins in the stomach that can occur in people with liver disease. These veins can bleed, causing serious complications. Lauromacrogol 400 is being studied as a treatment for gastric varices, often in combination with other substances.

In some studies, Lauromacrogol 400 is mixed with a substance called cyanoacrylate (a type of medical glue) and injected into the enlarged veins. This combination is being compared to other treatments to see which is most effective at preventing bleeding from gastric varices.

How is Lauromacrogol 400 Administered?

Lauromacrogol 400 is typically administered by a healthcare professional. The method of administration depends on the condition being treated:

  • For venous insufficiency: It's injected directly into the problematic veins, often guided by ultrasound.
  • For hemorrhoids: It's administered as a foam through an endoscope (a thin, flexible tube with a camera).
  • For gastric varices: It's often mixed with other substances and injected into the enlarged veins in the stomach during an endoscopic procedure.

Ongoing Research and Clinical Trials

Several clinical trials are currently underway to further investigate the effectiveness of Lauromacrogol 400 in various conditions:

  • Comparing different concentrations (1% vs 3%) for treating venous insufficiency.
  • Evaluating foam vs liquid forms for treating hemorrhoids.
  • Comparing Lauromacrogol 400 to other treatments for gastric varices.

These studies aim to determine the most effective and safe ways to use Lauromacrogol 400, potentially expanding its use in medical treatments.

Questions people often ask

Conditions where Lauromacrogol 400 is being studied

Each condition opens its own overview and trial list

Trials with Lauromacrogol 400

Recruiting trials first

See all 3 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).